Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Macrophage-Derived Chemokine MDC/CCL22: An Ambiguous Finding in COVID-19

23 Aug 2023

Abstract excerpt

Macrophage-derived chemokine (MDC/CCL22) is a chemokine of the C-C subfamily. It is involved in T-cellular maturation and migration. Our previous research shows that plasma CCL22/MDC tends to show a statistically significant depletion of concentrations in acute patients and convalescents when compared to healthy donors. In the current work, we investigate existing views on MDC/CCL22 dynamics in association with...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to COVID-19 Clinical Research Studies
Share to Long-Term Effects of COVID-19
Share to SARS-CoV-2 and COVID-19 Research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 37685890
DOI: 10.3390/ijms241713083

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Macrophage-Derived Chemokine MDC/CCL22: An Ambiguous Finding in COVID-19PMID 37685890Read ↗

Macrophage-Derived Chemokine MDC/CCL22: An Ambiguous Finding in COVID-19Semantic proximity Read ↗

Serum CCL17 level becomes a predictive marker to distinguish between mild/moderate and severe/critical disease in patients with COVID-19Semantic proximity Read ↗

Marked T cell activation, senescence, exhaustion and skewing towards TH17 in patients with Covid-19 pneumoniaSemantic proximity Read ↗

Chemokine Receptor Inhibitor vMIP-II Promoting Lymphocytes in COVID-19 Patients and Its Related Mechanism In VitroSemantic proximity Read ↗

Chemokine Receptor Inhibitor vMIP-II Promoting Lymphocytes in COVID-19 Patients and Its Related Mechanism In VitroSemantic proximity Read ↗

Local CCL18 and CCL21 expand lung fibrovascular niches and recruit lymphocytes, leading to tertiary lymphoid structure formation in prolonged COVID-19Semantic proximity Read ↗

CXCL10 Chemokine: A Critical Player in RNA and DNA Viral InfectionsSemantic proximity Read ↗

Monocyte chemoattractant protein-1 (MCP-1): an overview.Semantic proximity Read ↗

Chemokines in the immunopathogenesis of hepatitis C infection.Semantic proximity Read ↗

Chemokines and Their Receptors: Drug Targets in Immunity and InflammationSemantic proximity Read ↗

Alterations of TRIM21-mRNA expression during monocyte maturation.Semantic proximity Read ↗

The molecular structure and role of CCL2 (MCP‐1) and C‐C chemokine receptor CCR2 in skeletal biology and diseasesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.